EMEA (Europe, Middle East and Africa) Oral Controlled Drug Delivery System Market Report 2017

December 2017 | 117 pages | ID: EC5CD799F74EN
QYResearch

Abstracts

In this report, the EMEA Oral Controlled Drug Delivery System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Oral Controlled Drug Delivery System for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oral Controlled Drug Delivery System market competition by top manufacturers/players, with Oral Controlled Drug Delivery System sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca Plc.
• Mylan N.V.
• Sanofi
• F. Hoffman-La-Roche Ltd.
• Bristol-Myers Squibb Company
• Sun Pharmaceuticals Industries Ltd
• Abbott Laboratories
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Vectura Group plc.
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Diffusion Controlled Release System
• Dissolution Controlled Release System
• Ion Exchange Resins Controlled Release
• Hydro-dynamically Balanced Drug Delivery System
• Osmotically Controlled Release System
• Dissolution & Diffusion Controlled Release System

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Oral Controlled Drug Delivery System Market Report 2017

1 ORAL CONTROLLED DRUG DELIVERY SYSTEM OVERVIEW

1.1 Product Overview and Scope of Oral Controlled Drug Delivery System
1.2 Classification of Oral Controlled Drug Delivery System
  1.2.1 EMEA Oral Controlled Drug Delivery System Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Oral Controlled Drug Delivery System Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Diffusion Controlled Release System
  1.2.4 Dissolution Controlled Release System
  1.2.5 Ion Exchange Resins Controlled Release
  1.2.6 Hydro-dynamically Balanced Drug Delivery System
  1.2.7 Osmotically Controlled Release System
  1.2.8 Dissolution & Diffusion Controlled Release System
1.3 EMEA Oral Controlled Drug Delivery System Market by Application/End Users
  1.3.1 EMEA Oral Controlled Drug Delivery System Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Other
1.4 EMEA Oral Controlled Drug Delivery System Market by Region
  1.4.1 EMEA Oral Controlled Drug Delivery System Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oral Controlled Drug Delivery System (2012-2022)
  1.5.1 EMEA Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Oral Controlled Drug Delivery System Revenue and Growth Rate (2012-2022)

2 EMEA ORAL CONTROLLED DRUG DELIVERY SYSTEM COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Oral Controlled Drug Delivery System Market Competition by Players/Manufacturers
  2.1.1 EMEA Oral Controlled Drug Delivery System Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Oral Controlled Drug Delivery System Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Oral Controlled Drug Delivery System Sale Price by Players (2012-2017)
2.2 EMEA Oral Controlled Drug Delivery System (Volume and Value) by Type/Product Category
  2.2.1 EMEA Oral Controlled Drug Delivery System Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Oral Controlled Drug Delivery System Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Oral Controlled Drug Delivery System Sale Price by Type (2012-2017)
2.3 EMEA Oral Controlled Drug Delivery System (Volume) by Application
2.4 EMEA Oral Controlled Drug Delivery System (Volume and Value) by Region
  2.4.1 EMEA Oral Controlled Drug Delivery System Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Oral Controlled Drug Delivery System Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Oral Controlled Drug Delivery System Sales Price by Region (2012-2017)

3 EUROPE ORAL CONTROLLED DRUG DELIVERY SYSTEM (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Oral Controlled Drug Delivery System Sales and Value (2012-2017)
  3.1.1 Europe Oral Controlled Drug Delivery System Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Oral Controlled Drug Delivery System Revenue and Growth Rate (2012-2017)
3.2 Europe Oral Controlled Drug Delivery System Sales and Market Share by Type
3.3 Europe Oral Controlled Drug Delivery System Sales and Market Share by Application
3.4 Europe Oral Controlled Drug Delivery System Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Oral Controlled Drug Delivery System Sales Volume by Countries (2012-2017)
  3.4.2 Europe Oral Controlled Drug Delivery System Revenue by Countries (2012-2017)
  3.4.3 Germany Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.4 France Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.5 UK Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.6 Russia Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.7 Italy Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ORAL CONTROLLED DRUG DELIVERY SYSTEM (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Oral Controlled Drug Delivery System Sales and Value (2012-2017)
  4.1.1 Middle East Oral Controlled Drug Delivery System Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Oral Controlled Drug Delivery System Revenue and Growth Rate (2012-2017)
4.2 Middle East Oral Controlled Drug Delivery System Sales and Market Share by Type
4.3 Middle East Oral Controlled Drug Delivery System Sales and Market Share by Application
4.4 Middle East Oral Controlled Drug Delivery System Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Oral Controlled Drug Delivery System Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Oral Controlled Drug Delivery System Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  4.4.4 Israel Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  4.4.5 UAE Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  4.4.6 Iran Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)

5 AFRICA ORAL CONTROLLED DRUG DELIVERY SYSTEM (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Oral Controlled Drug Delivery System Sales and Value (2012-2017)
  5.1.1 Africa Oral Controlled Drug Delivery System Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Oral Controlled Drug Delivery System Revenue and Growth Rate (2012-2017)
5.2 Africa Oral Controlled Drug Delivery System Sales and Market Share by Type
5.3 Africa Oral Controlled Drug Delivery System Sales and Market Share by Application
5.4 Africa Oral Controlled Drug Delivery System Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Oral Controlled Drug Delivery System Sales Volume by Countries (2012-2017)
  5.4.2 Africa Oral Controlled Drug Delivery System Revenue by Countries (2012-2017)
  5.4.3 South Africa Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Oral Controlled Drug Delivery System Sales and Growth Rate (2012-2017)

6 EMEA ORAL CONTROLLED DRUG DELIVERY SYSTEM MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AstraZeneca Plc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Plc. Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Mylan N.V.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Mylan N.V. Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 F. Hoffman-La-Roche Ltd.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb Company
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Sun Pharmaceuticals Industries Ltd
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abbott Laboratories
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abbott Laboratories Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck & Co. Inc.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck & Co. Inc. Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Novartis AG
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Novartis AG Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Pfizer Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Oral Controlled Drug Delivery System Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Pfizer Inc. Oral Controlled Drug Delivery System Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Vectura Group plc.
6.12 GlaxoSmithKline plc.
6.13 Johnson & Johnson Services, Inc.

7 ORAL CONTROLLED DRUG DELIVERY SYSTEM MANUFACTURING COST ANALYSIS

7.1 Oral Controlled Drug Delivery System Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Controlled Drug Delivery System

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Controlled Drug Delivery System Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Controlled Drug Delivery System Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ORAL CONTROLLED DRUG DELIVERY SYSTEM MARKET FORECAST (2017-2022)

11.1 EMEA Oral Controlled Drug Delivery System Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Oral Controlled Drug Delivery System Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Oral Controlled Drug Delivery System Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Oral Controlled Drug Delivery System Price and Trend Forecast (2017-2022)
11.2 EMEA Oral Controlled Drug Delivery System Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oral Controlled Drug Delivery System Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oral Controlled Drug Delivery System Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oral Controlled Drug Delivery System Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oral Controlled Drug Delivery System Sales Forecast by Type (2017-2022)
11.7 EMEA Oral Controlled Drug Delivery System Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Controlled Drug Delivery System
Figure EMEA Oral Controlled Drug Delivery System Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Oral Controlled Drug Delivery System Sales Volume Market Share by Type (Product Category) in 2016
Figure Diffusion Controlled Release System Product Picture
Figure Dissolution Controlled Release System Product Picture
Figure Ion Exchange Resins Controlled Release Product Picture
Figure Hydro-dynamically Balanced Drug Delivery System Product Picture
Figure Osmotically Controlled Release System Product Picture
Figure Dissolution & Diffusion Controlled Release System Product Picture
Figure EMEA Oral Controlled Drug Delivery System Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Oral Controlled Drug Delivery System by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Oral Controlled Drug Delivery System Market Size (Million USD) by Region (2012-2022)
Figure Europe Oral Controlled Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oral Controlled Drug Delivery System Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oral Controlled Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oral Controlled Drug Delivery System Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oral Controlled Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oral Controlled Drug Delivery System Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oral Controlled Drug Delivery System Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oral Controlled Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oral Controlled Drug Delivery System Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Sales Share by Players (2012-2017)
Figure 2016 Oral Controlled Drug Delivery System Sales Share by Players
Figure 2017 Oral Controlled Drug Delivery System Sales Share by Players
Figure EMEA Oral Controlled Drug Delivery System Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Revenue (Million USD) by Players (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Revenue Share by Players (2012-2017)
Table 2016 EMEA Oral Controlled Drug Delivery System Revenue Share by Players
Table 2017 EMEA Oral Controlled Drug Delivery System Revenue Share by Players
Table EMEA Oral Controlled Drug Delivery System Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Sales Share by Type (2012-2017)
Figure Sales Market Share of Oral Controlled Drug Delivery System by Type (2012-2017)
Figure EMEA Oral Controlled Drug Delivery System Sales Market Share by Type (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Controlled Drug Delivery System by Type in 2016
Table EMEA Oral Controlled Drug Delivery System Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Sales Share by Application (2012-2017)
Figure Sales Market Share of Oral Controlled Drug Delivery System by Application (2012-2017)
Figure EMEA Oral Controlled Drug Delivery System Sales Market Share by Application in 2016
Table EMEA Oral Controlled Drug Delivery System Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Sales Share by Region (2012-2017)
Figure Sales Market Share of Oral Controlled Drug Delivery System by Region (2012-2017)
Figure EMEA Oral Controlled Drug Delivery System Sales Market Share in 2016
Table EMEA Oral Controlled Drug Delivery System Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oral Controlled Drug Delivery System Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oral Controlled Drug Delivery System by Region (2012-2017)
Figure EMEA Oral Controlled Drug Delivery System Revenue Market Share Regions in 2016
Table EMEA Oral Controlled Drug Delivery System Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Oral Controlled Drug Delivery System Revenue and Growth Rate (2012-2017)
Table Europe Oral Controlled Drug Delivery System Sales (K Units) by Type (2012-2017)
Table Europe Oral Controlled Drug Delivery System Market Share by Type (2012-2017)
Figure Europe Oral Controlled Drug Delivery System Market Share by Type in 2016
Table Europe Oral Controlled Drug Delivery System Sales (K Units) by Application (2012-2017)
Table Europe Oral Controlled Drug Delivery System Market Share by Application (2012-2017)
Figure Europe Oral Controlled Drug Delivery System Market Share by Application in 2016
Table Europe Oral Controlled Drug Delivery System Sales (K Units) by Countries (2012-2017)
Table Europe Oral Controlled Drug Delivery System Sales Market Share by Countries (2012-2017)
Figure Europe Oral Controlled Drug Delivery System Sales Market Share by Countries (2012-2017)
Figure Europe Oral Controlled Drug Delivery System Sales Market Share by Countries in 2016
Table Europe Oral Controlled Drug Delivery System Revenue (Million USD) by Countries (2012-2017)
Table Europe Oral Controlled Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Controlled Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Controlled Drug Delivery System Revenue Market Share by Countries in 2016
Figure Germany Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure France Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure UK Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Oral Controlled Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oral Controlled Drug Delivery System Sales (K Units) by Type (2012-2017)
Table Middle East Oral Controlled Drug Delivery System Market Share by Type (2012-2017)
Figure Middle East Oral Controlled Drug Delivery System Market Share by Type (2012-2017)
Table Middle East Oral Controlled Drug Delivery System Sales (K Units) by Applications (2012-2017)
Table Middle East Oral Controlled Drug Delivery System Market Share by Applications (2012-2017)
Figure Middle East Oral Controlled Drug Delivery System Sales Market Share by Application in 2016
Table Middle East Oral Controlled Drug Delivery System Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Oral Controlled Drug Delivery System Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oral Controlled Drug Delivery System Sales Volume Market Share by Countries in 2016
Table Middle East Oral Controlled Drug Delivery System Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oral Controlled Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Controlled Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Controlled Drug Delivery System Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oral Controlled Drug Delivery System Sales (K Units) by Type (2012-2017)
Table Africa Oral Controlled Drug Delivery System Sales Market Share by Type (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Sales Market Share by Type (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Sales Market Share by Type in 2016
Table Africa Oral Controlled Drug Delivery System Sales (K Units) by Application (2012-2017)
Table Africa Oral Controlled Drug Delivery System Sales Market Share by Application (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Sales Market Share by Application (2012-2017)
Table Africa Oral Controlled Drug Delivery System Sales Volume (K Units) by Countries (2012-2017)
Table Africa Oral Controlled Drug Delivery System Sales Market Share by Countries (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Sales Market Share by Countries (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Sales Market Share by Countries in 2016
Table Africa Oral Controlled Drug Delivery System Revenue (Million USD) by Countries (2012-2017)
Table Africa Oral Controlled Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Controlled Drug Delivery System Revenue Market Share by Countries in 2016
Figure South Africa Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Table AstraZeneca Plc. Oral Controlled Drug Delivery System Basic Information List
Table AstraZeneca Plc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Plc. Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca Plc. Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Plc. Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Mylan N.V. Oral Controlled Drug Delivery System Basic Information List
Table Mylan N.V. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan N.V. Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Mylan N.V. Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Mylan N.V. Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Sanofi Oral Controlled Drug Delivery System Basic Information List
Table Sanofi Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Sanofi Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Basic Information List
Table F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure F. Hoffman-La-Roche Ltd. Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Basic Information List
Table Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Company Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Basic Information List
Table Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Sun Pharmaceuticals Industries Ltd Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Oral Controlled Drug Delivery System Basic Information List
Table Abbott Laboratories Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Merck & Co. Inc. Oral Controlled Drug Delivery System Basic Information List
Table Merck & Co. Inc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Inc. Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Merck & Co. Inc. Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Merck & Co. Inc. Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Oral Controlled Drug Delivery System Basic Information List
Table Novartis AG Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis AG Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc. Oral Controlled Drug Delivery System Basic Information List
Table Pfizer Inc. Oral Controlled Drug Delivery System Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Inc. Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Inc. Oral Controlled Drug Delivery System Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc. Oral Controlled Drug Delivery System Revenue Market Share in EMEA (2012-2017)
Table Vectura Group plc. Oral Controlled Drug Delivery System Basic Information List
Table GlaxoSmithKline plc. Oral Controlled Drug Delivery System Basic Information List
Table Johnson & Johnson Services, Inc. Oral Controlled Drug Delivery System Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Controlled Drug Delivery System
Figure Manufacturing Process Analysis of Oral Controlled Drug Delivery System
Figure Oral Controlled Drug Delivery System Industrial Chain Analysis
Table Raw Materials Sources of Oral Controlled Drug Delivery System Major Manufacturers in 2016
Table Major Buyers of Oral Controlled Drug Delivery System
Table Distributors/Traders List
Figure EMEA Oral Controlled Drug Delivery System Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Controlled Drug Delivery System Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Controlled Drug Delivery System Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Oral Controlled Drug Delivery System Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Oral Controlled Drug Delivery System Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oral Controlled Drug Delivery System Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oral Controlled Drug Delivery System Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oral Controlled Drug Delivery System Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Oral Controlled Drug Delivery System Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oral Controlled Drug Delivery System Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oral Controlled Drug Delivery System Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Controlled Drug Delivery System Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Oral Controlled Drug Delivery System Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Controlled Drug Delivery System Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oral Controlled Drug Delivery System Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oral Controlled Drug Delivery System Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Oral Controlled Drug Delivery System Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oral Controlled Drug Delivery System Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oral Controlled Drug Delivery System Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oral Controlled Drug Delivery System Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Oral Controlled Drug Delivery System Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oral Controlled Drug Delivery System Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Oral Controlled Drug Delivery System Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources